Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy.
Derakhshani A, Rezaei Z, Safarpour H, Sabri M, Mir A, Sanati MA, Vahidian F, Gholamiyan Moghadam A, Aghadoukht A, Hajiasgharzadeh K, Baradaran B.
Derakhshani A, et al.
J Cell Physiol. 2020 Apr;235(4):3142-3156. doi: 10.1002/jcp.29216. Epub 2019 Sep 30.
J Cell Physiol. 2020.
PMID: 31566722
Review.